Literature DB >> 25280684

Biogenic gold nano-triangles: cargos for anticancer drug delivery.

Roopa Dharmatti1, Chinmay Phadke1, Ashmi Mewada1, Mukeshchand Thakur1, Sunil Pandey1, Madhuri Sharon2.   

Abstract

We present synthesis of biogenic gold nano triangles (GNTs) using Azadirachta indica leaf extract at inherent pH (5.89) and its application in efficient drug delivery of doxorubicin (DOX) (anticancer drug). The main idea was to take advantage of large surface area of GNTs which has 3 dimensions and use the plant peptides coated on these triangles as natural linkers for the attachment of DOX. Sucrose density gradient centrifugation (SDGC) and dialysis methods were used for separation of the GNT from mixture of GNPs. Flocculation parameter (FP) was used to check stability of GNT which was found to be exceptionally high (0-0.75) due to the biological capping agents. DOX attachment to GNT was verified using Fourier transformed infra-red (FTIR) spectroscopy. The complex thus formed was found to be less toxic to normal cells (MDCK cells) and significantly toxic for the cancerous cells (HeLa cells). Drug loading efficiency was found to be 99.81% and DOX release followed first order release kinetics. Percentage drug release was found to be more than 4.5% in both acidic (5.8) as well as physiological pH (7.2) which is suitable for tumor targeting.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biogenic-synthesis; Cytotoxicity; Drug release kinetics; Gold nano triangles; HeLa cells; MDCK cells

Mesh:

Substances:

Year:  2014        PMID: 25280684     DOI: 10.1016/j.msec.2014.08.006

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  2 in total

1.  Facile synthesis of anisotropic gold nanoparticles and its synergistic effect on breast cancer cell lines.

Authors:  Mubarak Jannathul Firdhouse; Pottail Lalitha
Journal:  IET Nanobiotechnol       Date:  2020-05       Impact factor: 1.847

2.  Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids.

Authors:  Wilfred Ngwa; Rajiv Kumar; Michele Moreau; Raymond Dabney; Allen Herman
Journal:  Front Oncol       Date:  2017-09-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.